AlphaMaven AlphaMaven

AlphaMaven Newsroom

Cannabis Investment News & Market Analysis

Latest cannabis investment news, regulatory updates, industry trends, and market analysis. Daily indices and insights for cannabis investors on AlphaMaven.

Updated 350 articles today
Get the Free Daily Briefing

Today's Cannabis Investment Headlines:

Featured Member Post

Big ideas need the right environment to thrive. At Fidelity, you'll be on the forefront of Alternative Investments, coll...

12h ago Hedge Fund Fidelity Careers

Steve Cohen’s 500th Bill Would Take Marijuana Out of the Controlled Substances Act Entirely  stupidDOPE

The exchange-traded fund market continues to grow spectacularly. State Street Investment Management expects net inflows...

Platinum Equity to Support Continued Investments in Sales, Marketing, Technology and Strategic Acquisitions LOS ANGELES,...

Rep. Steve Cohen Thinks the DEA Shouldn't Be Practicing Medicine  Reason Magazine

U.S. Congressmember Steve Cohen Introduces Bill to Deschedule Marijuana, Eliminate Mandatory Minimums and Overhaul Feder...

Weil Gotshal, a law firm that's represented NBA star Zion Williamson and other major sports industry clients, reportedly...

Baltimore-based Evermore Cannabis Co. must pay a $1.98 million arbitration award levied against it after it was found to...

Holland & Knight LLP partner Trisha Rich is at the forefront of the firm's work in a fast-growing corner of the lega...

Charlesbank Capital Partners has made an investment in WSHB Support Services, a newly formed management services organiz...

Chicago Atlantic Provides $17.5 Million Senior Secured Term Loan to Azuna Inc.  Business Wire

Beyond the headlines

Empower your investment and business decisions

These headlines are one slice of the AlphaMaven intelligence platform — synthesized continuously from public databases (60+ regulators), private partners (premium news wires and real-time market data services), and a 11K+ contributor network of industry members, cross-referenced to the firms, funds, and decision-makers behind every story.

Start your free 7-day trial

Cancel anytime · No contract